Trials / Conditions / Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies

Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies

13 registered clinical trials studyying Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies.

Status	Trial	Sponsor	Phase
Terminated	Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia NCT01801046	University of Southern California	Phase 1
Completed	Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoin NCT01371656	Children's Oncology Group	Phase 3
Completed	Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia NCT01076569	Children's Oncology Group	—
Completed	Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01146210	Children's Oncology Group	—
Completed	Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysp NCT00369317	Children's Oncology Group	Phase 3
Completed	Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, NCT00445744	Fred Hutchinson Cancer Center	N/A
Terminated	Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid NCT00096148	National Cancer Institute (NCI)	Phase 2
Completed	Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone To NCT00089011	Fred Hutchinson Cancer Center	Phase 2
Completed	Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Mali NCT00078858	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Imm NCT00014235	Fred Hutchinson Cancer Center	N/A
Completed	Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 i NCT00006363	National Cancer Institute (NCI)	Phase 3
Completed	Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin W NCT00003934	National Cancer Institute (NCI)	Phase 3
Completed	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogeno NCT00002798	National Cancer Institute (NCI)	Phase 3